TOP > 外国特許検索 > COMPOSITION FOR VASCULAR REGENERATION THERAPY, CONTAINING DEDIFFERENTIATED FAT CELLS AS ACTIVE INGREDIENT

COMPOSITION FOR VASCULAR REGENERATION THERAPY, CONTAINING DEDIFFERENTIATED FAT CELLS AS ACTIVE INGREDIENT 新技術説明会

外国特許コード F170008941
整理番号 (S2015-0856-N0)
掲載日 2017年1月20日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2016JP059386
国際公開番号 WO 2016158670
国際出願日 平成28年3月24日(2016.3.24)
国際公開日 平成28年10月6日(2016.10.6)
優先権データ
  • 特願2015-065598 (2015.3.27) JP
発明の名称 (英語) COMPOSITION FOR VASCULAR REGENERATION THERAPY, CONTAINING DEDIFFERENTIATED FAT CELLS AS ACTIVE INGREDIENT 新技術説明会
発明の概要(英語) The present invention addresses the problem of providing a cell for use in a vascular regeneration therapy, which has a superior blood flow-improving effect compared with a bone marrow-derived MSC, an ASC or the like that is a conventional cell for use in a therapy, and which can be obtained easily in an amount sufficient enough for transplantation, and which has stable quality. It is found that a human DFAT has a high neovascularization ability, can exhibit a high proliferation ability after being subcultured and therefore can be produced easily in an amount needed for transplantation, and does not undergo transformation. Therefore, it is found for the first time that a human DFAT is effective for a vascular regeneration therapy for a human body. These findings lead to the accomplishment of the present invention. That is, the present invention provides a blood flow-improving agent containing human dedifferentiated fat cells (human DFAT) as an active ingredient.
特許請求の範囲(英語) [claim1]
1. The human dedifferentiation fat cell (person DFAT) the blood style improvement medicines which are made the active ingredient.
[claim2]
2. The human dedifferentiation fat cell (person DFAT) the blood vessel new life accelerator which is made the active ingredient.
[claim3]
3. The human dedifferentiation fat cell (person DFAT) the *** characteristic diseased remedy medicine which is made the active ingredient.
[claim4]
4. The *** characteristic disease the peripheral artery disease (the PROPELLENT-ACTUATED DEVICE) or is the *** characteristic myocardial symptom, in claim 3 the *** characteristic diseased remedy medicine of statement.
[claim5]
5. The human dedifferentiation fat cell (person DFAT) is, 1-4 generation passage of generations the human dedifferentiation fat cell which was cultured (person DFAT), in either of the claim 1-4 the medicine of statement.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NIHON UNIVERSITY
  • 発明者(英語)
  • MATSUMOTO TARO
  • KANO KOICHIRO
  • KAZAMA TOMOHIKO
国際特許分類(IPC)
指定国 (WO2016158670)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
日本大学産官学連携知財センター(通称NUBIC,ニュービック)は,技術移転機関と知的財産本部の機能を兼ね備えた日本大学の産学連携の窓口です。
NUBICは,日本大学全教職員や大学院生・学部学生の豊富なアイデアや研究成果を,知的財産として戦略的に創出・保護・管理し,産業界のニーズとのマッチングを図り,企業の研究開発,新製品開発,新規事業の立上げが円滑に行われるようサポートいたします。
お気軽にご相談ください。

PAGE TOP

close
close
close
close
close
close